Variant report
Variant | nsv979925 |
---|---|
Chromosome Location | chr3:75887437-75892016 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573126119 | chr3:75888822-75888823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540539904 | chr3:75888876-75888877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs561489525 | chr3:75888877-75888878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536279666 | chr3:75888883-75888884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543952040 | chr3:75889008-75889009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560067066 | chr3:75889020-75889021 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77817776 | chr3:75889075-75889076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200407072 | chr3:75889083-75889084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201084035 | chr3:75889088-75889089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143190388 | chr3:75889104-75889105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572998732 | chr3:75889121-75889122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552402867 | chr3:75889137-75889138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs79465862 | chr3:75889160-75889161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528719470 | chr3:75889200-75889201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185700024 | chr3:75889213-75889214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545191843 | chr3:75889266-75889267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140380047 | chr3:75889275-75889276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535875549 | chr3:75889300-75889301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112586233 | chr3:75889306-75889307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs111292814 | chr3:75889311-75889312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376852536 | chr3:75889327-75889328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550785569 | chr3:75889350-75889351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs369171226 | chr3:75889365-75889366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372498568 | chr3:75889389-75889390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs190384014 | chr3:75889405-75889406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs200305529 | chr3:75889409-75889410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201389521 | chr3:75889414-75889415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs199726583 | chr3:75889432-75889433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191452273 | chr3:75889441-75889442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183582263 | chr3:75889457-75889458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573086658 | chr3:75889482-75889483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188662820 | chr3:75889497-75889498 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114837140 | chr3:75889498-75889499 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573543683 | chr3:75889512-75889513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs181244291 | chr3:75889522-75889523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186181570 | chr3:75889564-75889565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577274958 | chr3:75889573-75889574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544173723 | chr3:75889574-75889575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs564307442 | chr3:75889587-75889588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113460471 | chr3:75889589-75889590 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143549528 | chr3:75889599-75889600 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs199499607 | chr3:75889623-75889624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546961555 | chr3:75889638-75889639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562444295 | chr3:75889642-75889643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142508780 | chr3:75889678-75889679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371955063 | chr3:75889690-75889691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201504094 | chr3:75889695-75889696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs33927261 | chr3:75889710-75889711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529269133 | chr3:75889722-75889723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550905326 | chr3:75889735-75889736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Melanoma | 20877625 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:75888800-75889600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr3:75889200-75889400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr3:75889400-75890000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr3:75890000-75890400 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr3:75890400-75891800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr3:75891800-75892000 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |